Shares Homepage - BSE Sensex, NSE Nifty, Latest Prices, Live News, Company Search, Result Annoucements, Company News, Top stories, Gainers Losers, Top Performers, Market Commentary, Live Quotes, Bulk Deals
India's preferred Personal finance destination
Home Shares News Centre F&O Mutual Funds IPO Portfolio Commodity Loans Financial Planning Insurance About Us
Markets Companies Research Industries E-Mail Page
Wealth Tracker    Newsletter   Tax Corner NRI Centre Forums E-Mail Chat Masala Feedback
my Last 5 Scrips
Company BSE Price(Rs) % Chg
Hindalco 172.00 0.79
Tata Stl 522.85 0.41
Ong Corp 427.75 2.31
Bhel 229.20 1.29
Tata Mot 521.60 1.70
Clear All Clear Last
Shares
NSE Live
Nifty Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
BSE Live
BSE30 Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
IPO Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Discussion Forum
Research
Research Reports
Sector Watch
Economy Watch
Snapshot-Divis Laboratories Limited
Divis Laboratories Limited
Sector:Pharmaceuticals Pharmaceuticals - Pharmaceuticals - Others
BSE:532488NSE:DIVISLABBloomberg:DIVI@INReuters:DIVI.BO
Market Lot: 1Face Value: 2ISIN Demat: INE361B01024
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Recent Developments
26-MAY-14 During the quarter, the profit of the company rose 8.78% to Rs 1,964.30 million from Rs 1,805.70 million in the same quarter previous year. 08-NOV-13 Divis Laboratories, a pharmaceutical ingredients and intermediates company, today reported a rise of 73.71% in its net profit to Rs 2.05 billion for the quarter ended Sept. 30, 2013 as compared to Rs 1.18 billion in the same period last year. 03-AUG-13 Divis Laboratories, a pharmaceut...   More..
Business Profile Future Plans
One To One
Recent news
Latest News
Divis Laboratories falls on weak Q1 numbers  -IRIS 12-Aug-14
Previous

More


Brief Financials (in Rs. Mn.) 
Period ending (months)30-Jun-2014(3)31-Mar-2014 (12)31-Mar-2013(12)
Net sales 6397.6025071.8021239.50
Other Income126.90839.00790.40
Total Income6524.5025910.8022029.90
Cost of goods sold4074.9014951.1013376.70
OPBDIT2449.6010959.708653.20
PAT1679.307917.206114.20
Gross Block---
Equity capital265.50265.50265.50
EPS (Rs.)-59.65-
DPS (Rs.)---
BV (Rs.)---
P/E range (x)-15.17 - 24.46-
Debt / Equity (x)---
Operating margin (% of OI)37.542.339.3
Net margin (% of OI)25.730.627.8
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
ADDRESS
7-1-77/E/1/303
Divi Towers
Dharam Karan Road
Ameerpet
Hyderabad
Andhra Pradesh-500 016
PHONE
(040) 2378 6300
FAX
(040) 2378 6460
 
Board of Directors
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Trade On-line | Wealth Tracker | Newsletters | Tax Corner | NRI Centre | Forums | E-mail | Chat | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer